Bcl2-negative MCF7 cells overexpress p53: Implications for the cell cycle and sensitivity to cytotoxic drugs

Cancer Chemotherapy and Pharmacology

Volumn 50, Issue 2, 2002, Pages 127-130

  Poliseno, Laura ^a   Mariani, Laura ^a   Collecchi, Paola ^b   Piras, Antonio ^a   Zaccaro, Lucia ^b   Rainaldi, Giuseppe ^a  

^a CNR   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Apoptosis; Bcl2; Cell cycle; Drug sensitivity; P53

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; PROTEIN BCL 2; PROTEIN KINASE INHIBITOR; PROTEIN P53; STAUROSPORINE;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR NECROSIS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CISPLATIN; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, BCL-2; GENES, P53; HUMANS; MITOCHONDRIA; STAUROSPORINE; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036351292     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0467-x     Document Type: Article

References (27)

1. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: Cross-talk with p53 signaling pathway
2. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins
3. Ribozyme targeting demonstrates that the nuclear receptor coactivator aib1 is a rate-limiting factor for estrogen-dependent growth of human mcf-7 breast cancer cells
4. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation
5. Subcellular and submitochondrial mode of action of Bcl2-like oncoproteins
6. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug induced apoptosis of human tumor cells
7. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect
8. Preclinical perspectives on platinum resistance
9. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
10. Reduction of proliferative heterogeneity of CHEF18 Chinese hamster cell line during the progression toward tumorigenicity
11. Mitochondrial control of cell death
12. Molecular mechanisms involved in cisplatin cytotoxicity
13. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle
14. p53 and chemosensitivity
15. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases
16. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
17. Interaction with p53 enhances binding of cisplatin-modified DNA by High Mobility Group 1 protein
18. Mechanisms of p53-mediated apoptosis
19. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells
20. Role of three cancer "master genes" p53, bcl2 and c-myc on the apoptotic process
21. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter
22. p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE
23. Inhibition of p53 transcriptional activity by Bcl-2 requires its membrane-anchoring domain
24. Inhibition of CDKs as a therapeutic modality
25. Caspase-8 activation and bid cleavage contribute to MCF-7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis
26. Fas-mediated apoptosis of proliferating, transiently growth-arrested and senescent normal human fibroblasts
27. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells